Unibest
← Back to patent-cliff list

CAS 93267-04-0

(R)-methyl 2-((tert-butoxycarbonyl)amino)-3-iodopropanoate

Codes: ACT-246475-001

Application context (from source-drug indications)

Myocardial infarctionSelatogrel慢性冠脉综合征SelatogrelHepatic function declineSelatogrelCoronary artery lesionSelatogrel

Source drugs (routes using this intermediate)

DrugTierExpiry
SelatogrelTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Sitemethyl (R)-2-((tert-butoxycarbonyl)amino)-3-iodopropanoate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API WorksBoc-Beta-iodo-Ala-Ome
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Worksmethyl (R)-2-((tert-butoxycarbonyl)amino)-3-iodopropanoate
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.